A mid-size pharmaceutical intermediates manufacturer in Gujarat, India producing APIs and advanced intermediates for generic drug formulations. The client required consistent, high-purity chemical raw materials including solvents, catalysts, and reagents.
The client's existing supply chain involved multiple small traders with inconsistent quality and documentation. Key raw materials including DMSO, DMF, boric acid, and various organic intermediates frequently arrived with incomplete COA documentation, causing production delays and regulatory audit concerns.
Zorui consolidated the client's chemical raw material supply into a single, reliable source. We provided pharmaceutical-grade DMSO, DMF, boric acid, sodium acetate, and specialty intermediates with complete analytical documentation. We implemented a just-in-time delivery schedule to match production requirements.
Supply chain consolidation reduced procurement complexity by 70%. Raw material costs decreased by 25% through direct factory pricing. Consistent quality eliminated production batch rejections. The client passed FDA and WHO-GMP audits with complete raw material traceability documentation.
A mid-size pharmaceutical intermediates manufacturer in Gujarat, India producing APIs and advanced intermediates for generic drug formulations. The client required consistent, high-purity chemical raw materials including solvents, catalysts, and reagents.
The client's existing supply chain involved multiple small traders with inconsistent quality and documentation. Key raw materials including DMSO, DMF, boric acid, and various organic intermediates frequently arrived with incomplete COA documentation, causing production delays and regulatory audit concerns.
Zorui consolidated the client's chemical raw material supply into a single, reliable source. We provided pharmaceutical-grade DMSO, DMF, boric acid, sodium acetate, and specialty intermediates with complete analytical documentation. We implemented a just-in-time delivery schedule to match production requirements.
Supply chain consolidation reduced procurement complexity by 70%. Raw material costs decreased by 25% through direct factory pricing. Consistent quality eliminated production batch rejections. The client passed FDA and WHO-GMP audits with complete raw material traceability documentation.